National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Childhood Supratentorial Primitive Neuroectodermal Tumors and Pineoblastoma Treatment (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 04/09/2008



Purpose of This PDQ Summary






General Information






Cellular Classification







Stage Information






Treatment Option Overview






Untreated Childhood Supratentorial Primitive Neuroectodermal Tumors and Pineoblastoma






Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumors and Pineoblastoma






Get More Information From NCI






Changes to This Summary (04/09/2008)






More Information



Page Options
Print This Page  Print This Page
Print This Document  Print Entire Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Stage Information

Poorly differentiated small round cell tumors of the cerebrum have been referred to as cerebral neuroblastoma and as primitive neuroectodermal tumors. These tumors in the pineal body have classically been called pineoblastomas. Histologically, these tumors may be similar to cerebellar medulloblastoma with varying proportions of features that suggest astrocytic or ependymal differentiation. Genetic aberrations of supratentorial brain tumors appear to be different from those of infratentorial primitive neuroectodermal tumors (PNET, medulloblastoma).[1] Tumors may spread throughout the subarachnoid space. Every patient with a primitive neuroectodermal tumor or with pineoblastoma should be evaluated with diagnostic imaging of the spinal cord and whole brain. The most sensitive method currently available for evaluating spinal cord subarachnoid metastasis is spinal magnetic resonance imaging performed with gadolinium. Cerebrospinal fluid should be examined cytologically for tumor cells. There is no generally accepted staging system for supratentorial primitive neuroectodermal tumors and for pineoblastomas, but the staging system used for medulloblastoma is conventionally used for tumor dissemination. Prognosis is probably related to the extent of disease both at diagnosis and after surgery.[2-5] Patients with cystic tumors may fare better.  [Note: 2-year survival rate: 30% to 50%]

References

  1. Russo C, Pellarin M, Tingby O, et al.: Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors. Cancer 86 (2): 331-9, 1999.  [PUBMED Abstract]

  2. Edwards MS, Hudgins RJ, Wilson CB, et al.: Pineal region tumors in children. J Neurosurg 68 (5): 689-97, 1988.  [PUBMED Abstract]

  3. Disclafani A, Hudgins RJ, Edwards MS, et al.: Pineocytomas. Cancer 63 (2): 302-4, 1989.  [PUBMED Abstract]

  4. D'Andrea AD, Packer RJ, Rorke LB, et al.: Pineocytomas of childhood. A reappraisal of natural history and response to therapy. Cancer 59 (7): 1353-7, 1987.  [PUBMED Abstract]

  5. Abay EO 2nd, Laws ER Jr, Grado GL, et al.: Pineal tumors in children and adolescents. Treatment by CSF shunting and radiotherapy. J Neurosurg 55 (6): 889-95, 1981.  [PUBMED Abstract]

Back to TopBack to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov